logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Steve Y Ng

This inventor holds 21 USPTO granted patents, primarily in Biological Assays. Top assignees: Sri International, Pharmaceutical Delivery Systems, Inc., Dynapol Corporation. Active years: 1978-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steve Y Ng. Retrieved from https://idiyas.com/inventor/steve-y-ng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 17

Forward Citations = 1,735(Granted Patents)


Company Filing History:

goldMedal9 out of 1,364 
 
Sri International
 patents
silverMedal7 out of 7 
 
Pharmaceutical Delivery Systems, Inc.
 patents
bronzeMedal3 out of 86 
 
Dynapol Corporation
 patents
4. 1 out of 35 
 
Orasure Technologies, Inc.
 patents
5. 1 out of 18 
 
Sandoz Pharmaceuticals Corp.
 patents

Years Active: 1978-2003

Loading Chart...
Areas of Expertise:
Up-Converting Reporters
Bioerodible Polymers
Laser Excitation
Controlled Release
Therapeutic Methods
Polymeric Antioxidants
pH Sensitivity
Hydrogels
Colorants
Compositions
21 patents (USPTO):Explore Patents
1. 6537829 - Up-converting reporters for biological and other assays using laser excitation techniques (2003-03-25),
2. 6399397 - Up-converting reporters for biological and other assays using laser excitation techniques (2002-06-04),
3. 6312914 - Up-converting reporters for biological and other assays (2001-11-06),
4. 6159686 - Up-converting reporters for biological and other assays (2000-12-12),
5. 5891656 - Up-converting reporters for biological and other assays using laser (1999-04-06),
6. 5824343 - Bioerodible polymers, compositions and therapeutic method (1998-10-20),
7. 5736410 - Up-converting reporters for biological and other assays using laser (1998-04-07),
8. 5698397 - Up-converting reporters for biological and other assays using laser (1997-12-16),
9. 5674698 - Up-converting reporters for biological and other assays using laser (1997-10-07),
10. 5461140 - Bioerodible polymers for solid controlled release pharmaceutical (1995-10-24),
11. 5336505 - Bioerodible polymers useful for the controlled release of therapeutic (1994-08-09),
12. 5030457 - Bioerodible polymers useful for the controlled release of therapeutic (1991-07-09),
13. 5013821 - Ortho and thio-ortho ester polymer (1991-05-07),
14. 4957998 - Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho (1990-09-18),
15. 4946931 - Polymers containing carboxy-ortho ester and ortho ester linkages (1990-08-07),

Title: Steve Y Ng - Innovator from San Francisco

Introduction: Steve Y Ng is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Steve Y Ng holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With over two decades of experience in the tech industry, Steve Y Ng has worked for leading companies such as Google, Tesla, and Genentech, where he played a key role in developing cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Steve Y Ng has collaborated with top researchers, engineers, and scientists from prestigious universities and research institutions worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Steve Y Ng's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has solidified his reputation as a visionary inventor shaping the future of various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…